52
Participants
Start Date
August 31, 2004
Primary Completion Date
July 31, 2007
Study Completion Date
July 31, 2007
Adalimumab (Humira)
Adalimumab (Humira) 40 mg subcutaneously every other week
Department of Rheumatology, Copenhagen University Hospital, Rigshospitalet, Copenhagen
Department of Rheumatology, Bispebjerg University Hospital, Copenhagen
Department of Rheumatology, Gentofte University Hospital, Hellerup
Department of Rheumatology, Herlev University Hospital, Herlev
Department of Rheumatology, Hvidovre University Hospital, Hvidovre
Collaborators (1)
Abbott
INDUSTRY
Hvidovre University Hospital
OTHER